The shares of Esperion Therapeutics Inc. (ESPR) have recorded the market capitalization of 390.26M
The stock of Esperion Therapeutics Inc. (NASDAQ:ESPR) last traded at $2.29, up 8.53% from the previous session. ESPR stock price is now -4.30% away from the 50-day moving average and 37.68% away from the 200-day moving average. The market capitalization of the company currently stands at $390.26M. , while ‘Northland Capital’ rates the stock as […]
The most important numbers to know about Esperion Therapeutics Inc. (NASDAQ:ESPR)
Esperion Therapeutics Inc. (NASDAQ:ESPR) shares traded 4.72% higher at $1.33 on Wall Street last session. In accordance with the data, 9 analysts cover Esperion Therapeutics Inc. (NASDAQ:ESPR). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $22.00 and a low of $2.00, […]
There’s Something Awry at Esperion Therapeutics Inc. (NASDAQ:ESPR) Since Share Price Gets Ahead of Fundamentals
The stock of Esperion Therapeutics Inc. (NASDAQ:ESPR) last traded at $1.11, down -3.48% from the previous session. Data from the available sources indicates that Esperion Therapeutics Inc. (NASDAQ:ESPR) is covered by 8 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of […]
Could Esperion Therapeutics Inc. (ESPR) stock price achieve new all-time highs if its expected earnings and revenue increase?
In yesterday’s Wall Street session, Esperion Therapeutics Inc. (NASDAQ:ESPR) shares traded at $0.88, down -10.79% from the previous session. As of this writing, 8 analysts cover Esperion Therapeutics Inc. (NASDAQ:ESPR). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $22.00 and a […]
How Do Esperion Therapeutics Inc. (NASDAQ:ESPR)’s Fundamentals Affect Performance
The price of Esperion Therapeutics Inc. (NASDAQ:ESPR) shares last traded on Wall Street fell -6.26% to $0.91. Based on available information, 8 analysts follow Esperion Therapeutics Inc. (NASDAQ:ESPR). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $22.00 and a low of […]
Is Esperion Therapeutics Inc. (NASDAQ:ESPR) being unfairly punished by investors?
The price of Esperion Therapeutics Inc. (NASDAQ:ESPR) shares last traded on Wall Street fell -6.10% to $0.99. ESPR stock price is now -32.43% away from the 50-day moving average and -66.56% away from the 200-day moving average. The market capitalization of the company currently stands at $105.48M. In other news, Warren Eric, Chief Commercial Officer […]
A breakdown of the latest mutual funds holding Esperion Therapeutics Inc. (ESPR)
Stocks of Esperion Therapeutics Inc. (NASDAQ:ESPR) traded higher last session on Wall Street, down -5.22% to $1.09. According to the data, Esperion Therapeutics Inc. (NASDAQ:ESPR) has 8 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $22.00 and […]
The shares of Esperion Therapeutics Inc. (ESPR) have recorded the market capitalization of 138.00M
The stock of Esperion Therapeutics Inc. (NASDAQ:ESPR) last traded at $1.29, down -3.73% from the previous session. Data from the available sources indicates that Esperion Therapeutics Inc. (NASDAQ:ESPR) is covered by 9 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of […]
What is Esperion Therapeutics Inc.’s (NASDAQ:ESPR) current market value? Can you beat the fundamentals?
In yesterday’s Wall Street session, Esperion Therapeutics Inc. (NASDAQ:ESPR) shares traded at $1.63, up 3.16% from the previous session. 9 analysts cover Esperion Therapeutics Inc. (NASDAQ:ESPR), according to research data. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $22.00 and a […]
There’s Something Awry at Esperion Therapeutics Inc. (NASDAQ:ESPR) Since Share Price Gets Ahead of Fundamentals
The stock of Esperion Therapeutics Inc. (NASDAQ:ESPR) last traded at $1.44, down -5.88% from the previous session. Data from the available sources indicates that Esperion Therapeutics Inc. (NASDAQ:ESPR) is covered by 9 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of […]